The Power of ddPCR Technology

Reproducibility from Absolute Quantification

Discover the power of BCR-ABL testing on Bio-Rad's QXDx AutoDG ddPCR System

The QXDx BCR-ABL %IS Kit is the first and only FDA-cleared BCR-ABL test utilizing droplet digital PCR technology.

Learn more about Bio-Rad's BCR-ABL kit for testing on the QXDx ddPCR System.

Contact a Bio-Rad representative today.

Thank you. A specialist will contact you shortly.

QXDx BCR-ABL %IS Kit

The best way to assess complete molecular response (CMR) is with a highly sensitive molecular assay. The QXDx BCR-ABL %IS Kit elevates chronic myeloid leukemia (CML) monitoring to a new level of reproducibility and precision with the sensitivity of 0.0028%IS and MR 4.56 with 2 wells. Bio-Rad's BCR-ABL assay delivers a reliable and robust workflow for monitoring chronic myeloid leukemia patients.

The ddPCR Power Advantage

Absolute Quantification
Provides an absolute count of target DNA copies per input sample without the need for standard curves.

Unparalleled Reproducibility
Harnesses the direct quantification of Droplet Digital PCR (ddPCR) and removes the hidden errors created by standard curves.

Unmatched Precision and Sensitivity
Enriched template concentration in target-positive droplets allows for higher precision and sensitivity than real-time PCR.

QXDx AutoDG ddPCR System

  • The first and only FDA-cleared ddPCR system

System Includes:

  • QXDx Automated Droplet Generator
  • QXDx Droplet Reader

QXDx BCR-ABL %IS Kit Workflow

Bio-Rad's Clinical ddPCR Reagents

QXDx AutoDG Consumable Pack

QXDx Droplet Reader Oil

QXDx AutoDG Consumable Pack

(Not required to run QXDx BCR-ABL %IS Kit)

Bio-Rad

Advance Discovery.
Improve Lives.

Bio-Rad and the Bio-Rad logo are trademarks of Bio-Rad Laboratories, Inc.
All Bio-Rad products and services presented in this site are trademarks or copyrights of Bio-Rad Laboratories, Inc. in various jurisdictions.

Copyright © 2018 Bio-Rad Laboratories, Inc.
4000 Alfred Nobel Drive, Hercules, CA 94547, USA